Product NDC: | 0703-0031 |
Proprietary Name: | Methylprednisolone Acetate |
Non Proprietary Name: | Methylprednisolone Acetate |
Active Ingredient(s): | 40 mg/mL & nbsp; Methylprednisolone Acetate |
Administration Route(s): | INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-0031 |
Labeler Name: | Teva Parenteral Medicines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040557 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050308 |
Package NDC: | 0703-0031-04 |
Package Description: | 25 VIAL, GLASS in 1 CARTON (0703-0031-04) > 1 mL in 1 VIAL, GLASS |
NDC Code | 0703-0031-04 |
Proprietary Name | Methylprednisolone Acetate |
Package Description | 25 VIAL, GLASS in 1 CARTON (0703-0031-04) > 1 mL in 1 VIAL, GLASS |
Product NDC | 0703-0031 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methylprednisolone Acetate |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | INTRAMUSCULAR; INTRASYNOVIAL; SOFT TISSUE |
Start Marketing Date | 20050308 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | METHYLPREDNISOLONE ACETATE |
Strength Number | 40 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |